Target intelligence / Profile preview

Hepatitis A Virus (HAV)

Target
HAV
Molecular classification
Virus, Picornaviridae, RNA virus
01

Overview

Hepatitis A virus (HAV) is a non-enveloped, single-stranded RNA virus that causes hepatitis A, an acute infectious disease of the liver. It spreads primarily via the fecal-oral route and is highly contagious. While it does not cause chronic infection, it can lead to liver inflammation and, rarely, fulminant hepatitis. Diagnosis relies on serological testing. Prevention involves vaccination and improved hygiene practices.

02

Mechanism of action

Vaccination stimulates the production of neutralizing antibodies; experimental monoclonal antibodies block viral attachment to host cells.

03

Biological functions

Viral replicationInfectionHepatocyte entry
04

Disease associations

Hepatitis ALiver inflammationInfection
05

Safety considerations

Contamination of food and waterRisk of outbreaks in areas with poor sanitationRare cases of fulminant hepatitisLack of specific antiviral treatments
06

Interacting drugs

Hepatitis A vaccine

1 more in the full profile.

07

Biomarkers

Anti-HAV IgMTotal anti-HAV antibodies (IgG + IgM)

Beyond the preview

Go deeper on Hepatitis A Virus (HAV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis A Virus (HAV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call